Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 77.20% is 187% above its 5-year average of 26.94%, near the high end of its 5-year range (0.00%–77.20%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.36% above its 12-month average of 59.68%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 77.20%.
DEBT TO ASSETS RATIO
77.20%
DEBT TO ASSETS RATIO AVG TTM
59.68%
DEBT TO ASSETS RATIO AVG 3Y
56.25%
DEBT TO ASSETS RATIO AVG 5Y
26.94%
DEBT TO ASSETS RATIO AVG 10Y
0.11%
DEBT TO ASSETS RATIO AVG 15Y
24.60%
DEBT TO ASSETS RATIO AVG 20Y
23.78%
CURRENT VS TTM AVG
+29.36%
CURRENT VS 3Y AVG
+37.23%
CURRENT VS 5Y AVG
+186.52%
CURRENT VS 10Y AVG
+73156.48%
CURRENT VS 15Y AVG
+213.87%
CURRENT VS 20Y AVG
+224.69%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 584 covered companies
CURRENT VS SECTOR MEDIAN
+77097.89%
vs the sector median at left
Dyadic International, Inc.
Market Cap
$17.20M
Debt to Assets Ratio
77.20%
TTM Avg
59.68%
3Y Avg
56.25%
5Y Avg
26.94%
Market Cap
$17.67M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.64M
Debt to Assets Ratio
0.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.80M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.58M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.86M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.88M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyadic International, Inc. (DYAI) | $17.20M | 77.20% | 59.68% | 56.25% | 26.94% |
| Lipocine Inc. (LPCN)vs › | $17.39M | 0.00% | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.67M | 0.00% | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | 0.14% | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.80M | 0.69% | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | 0.06% | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.58M | 0.29% | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.86M | 0.00% | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.88M | 0.00% | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $19.12M | 0.26% | N/A | N/A | N/A |
Debt/Assets
77.2%
Debt/Equity
N/A
Current Ratio
1.65
Interest Coverage
-15.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 77.20% |
| 2026-03-31 | 64.71% |
| 2025-12-31 | 50.88% |
| 2025-09-30 | 43.37% |
| 2025-06-30 | 62.22% |
| 2025-03-31 | 64.16% |
| 2024-12-31 | 51.02% |
| 2024-09-30 | 49.69% |
| 2024-06-30 | 52.35% |
| 2024-03-31 | 46.94% |
| 2023-12-31 | 1.67% |
| 2023-09-30 | 1.60% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.07% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 78.93% |
| 2015-06-30 | 90.04% |
| 2015-03-31 | 95.28% |
| 2014-12-31 | 95.32% |
| 2014-09-30 | 79.32% |
| 2014-06-30 | 73.81% |
| 2014-03-31 | 60.82% |
| 2013-12-31 | 55.17% |
| 2013-09-30 | 57.58% |
| 2013-06-30 | 53.06% |
| 2013-03-31 | 72.12% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2006-12-31 | 5.69% |
| 2006-09-30 | 9.97% |
| 2006-06-30 | 9.77% |
| 2006-03-31 | 18.67% |
| 2005-12-31 | 1.13% |
| 2005-09-30 | 15.09% |
| 2005-06-30 | 13.43% |
| 2005-03-31 | 11.93% |
| 2004-12-31 | 10.49% |
| 2004-09-30 | 5719.45% |
| 2004-06-30 | 99.14% |
| 2004-03-31 | 3.86% |
| 2003-12-31 | 0.00% |
